Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Portal hypertensive gastropathy

H H Trevino1, C E Brady, S Schenker

  • 1Department of Medicine, University of Texas Health Science Center at San Antonio, USA.

Digestive Diseases (Basel, Switzerland)
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Giardiasis in a hematopoietic stem cell transplant patient.

Transplant infectious disease : an official journal of the Transplantation Society·2014
Same author

Pioglitazone in the treatment of NASH: the role of adiponectin.

Alimentary pharmacology & therapeutics·2010
Same author

Failed jump landing trials: deficits in neuromuscular control.

Scandinavian journal of medicine & science in sports·2007
Same author

Does the NHS need celebrity chefs to spice up hospital food?

Nursing times·2002
Same author

In utero ethanol exposure causes mitochondrial dysfunction, which can result in apoptotic cell death in fetal brain: a potential role for 4-hydroxynonenal.

Alcoholism, clinical and experimental research·2001
Same author

The effects of food restriction in man on hepatic metabolism of acetaminophen.

Clinical nutrition (Edinburgh, Scotland)·2001
Same journal

Pancreatitis in Familial Dysautonomia Patients.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Treatment outcomes with empirical Clarithromycin-based triple therapy for Helicobacter pylori in Zambia, sub-Saharan Africa.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Endoscopic submucosal dissection-associated bacteremia: proper antibiotic management.

Digestive diseases (Basel, Switzerland)·2026
Same journal

The investigation and treatment of Helicobacter pylori for the prevention of gastric cancer: A narrative review and assessment of management approaches.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Analysis of Helicobacter pylori resistance and its trends in Chongqing: A 10-year retrospective study.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Early-onset colorectal cancer in Australia: environmental, microbial, and policy implications.

Digestive diseases (Basel, Switzerland)·2026
See all related articles

Portal hypertensive gastropathy (PHG) causes gastric bleeding in chronic liver disease patients. Propranolol shows promise in controlling severe PHG bleeding, alongside shunt procedures.

Area of Science:

  • Gastroenterology
  • Hepatology
  • Internal Medicine

Background:

  • Portal hypertensive gastropathy (PHG) is a complication of chronic liver disease and portal hypertension (PHTN).
  • Endoscopic findings include a mosaic-like pattern and red marks, indicative of potential gastric bleeding.
  • Severe PHG is the form most likely to cause hemorrhage.

Purpose of the Study:

  • To explore the pathogenesis of PHG and hemodynamic changes in PHTN.
  • To identify effective management strategies for bleeding PHG.
  • To evaluate the efficacy of propranolol and surgical interventions.

Main Methods:

  • Review of existing literature on PHG and PHTN.
  • Analysis of endoscopic findings and bleeding sources.

Related Experiment Videos

  • Evaluation of treatment outcomes for propranolol, TIPS, and shunt procedures.

    • Main Results:

    • Chronic increase in portal pressure is essential for PHG development.
    • Altered endogenous vasodilator and vasoconstrictor activity may contribute to circulatory disturbances.
    • H2 receptor antagonists and sucralfate are ineffective for bleeding PHG.
    • Propranolol demonstrated effectiveness in arresting mucosal hemorrhage in small studies.

    Conclusions:

    • PHG management requires addressing underlying portal hypertension.
    • Propranolol is a potential therapeutic option for severe bleeding PHG.
    • Transjugular intrahepatic portal-systemic shunt (TIPS) and portal-systemic shunt procedures are alternative interventions.